Patent ID: 6114345
Filing Date: 2000-09-05
Classification: A61P,C07J

Abstract:
A method for treating prostatic cancer and chemoprevention of benign prostatic hyperplasia or of prostatic cancer, comprising administering to a patient in need thereof an effective amount of a compound of formula (I): ##STR12## wherein: the symbol --- represents a single or a double bond;R is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group;R.sub.f and R'.sub.f, each independently, are perfluoro C.sub.1 -C.sub.4 alkyl groups;R.sub.1 and R.sub.2, each independently, are selected from the group consisting of:a hydrogen atom; a phenyl group; a C.sub.1 -C.sub.4 alkyl group unsubstituted or substituted by one or more fluorine atoms; a halogen atom; a cyano (CN) group; a group OR.sub.4, wherein R.sub.4 is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; a group SR.sub.5, wherein R.sub.5 is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; and a group COR.sub.6, wherein R.sub.6 is a group OR.sub.4 in which R.sub.4 is as defined above or a C.sub.1 -C.sub.4 alkyl group unsubstituted or substituted by one or more fluorine atoms.